The total pharmaceutical market of Sri Lanka is approximately US$ 365 million of which the private retail market accounts for approximately 60% of sales while the government hospital purchases account for approximately 28%, private hospitals account for approximately 10% and dispensing family physicians account for approximately 2% of the total pharmaceutical business. According to independent market research the pharmaceutical market has grown by 24.1% (IMS: MAT Q4/ 2010) versus the same period last year indicating much promise for a bright future.

The end of the war against terror which clouded the progress of Sri Lanka for the last 3 decades has now brought about a new lease of life to the country’s progress which will no doubt have a positive effect also on the healthcare sector in Sri Lanka. As it is, the Sri Lankan healthcare sector can boast of being on par with the high standards of the developed world and further expansion into more rural areas as well as the development of the northern and eastern regions of the country which had deteriorated due to the war will create further potential for growth and expansion of the private healthcare sector and thus the future opportunities in the pharmaceutical industry look very promising.

For detailed Sri Lankan health statistics please Click Here